Free Webex Call
The Veterinary Stereotactic Radiosurgery System Market was valued at USD 3.46 Billion in 2024, and is expected to reach USD 6.21 Billion by 2030, rising at a CAGR of 10.22%. This growth is driven by the increasing prevalence of cancer among companion animals, especially dogs and cats, prompting pet owners to seek advanced and non-invasive treatment solutions. Veterinary stereotactic radiosurgery (SRS) offers precise, high-dose radiation therapy targeted at tumors while minimizing damage to healthy tissue. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Its growing adoption is supported by rising awareness of veterinary oncology options, as well as continuous innovation in devices tailored for animal-specific needs. The market is further fueled by increasing global pet ownership and enhanced standards of pet healthcare, which have expanded access to sophisticated treatments. As veterinary clinics and specialty hospitals adopt more cutting-edge technologies, the demand for SRS systems continues to rise. Additionally, advancements in veterinary diagnostics and oncology are enabling more accurate, personalized care, contributing to the expansion of this market segment across both developed and emerging economies.
Key Market Drivers
Growing Pet Ownership
The expansion of global pet ownership is a pivotal factor in the growth of the Veterinary Stereotactic Radiosurgery System market. With more households adopting pets, there is a corresponding increase in demand for high-quality veterinary healthcare. Particularly in developed regions, pets are increasingly regarded as family members, prompting owners to pursue advanced treatments such as SRS. This trend is also extending to emerging markets where improved access to veterinary services is enabling broader adoption of cutting-edge solutions. As the pet population grows and owners become more informed about specialized care, the demand for precise, non-invasive cancer treatment options like SRS is expected to continue climbing.Key Market Challenges
Limited Availability of Specialized Veterinary Oncologists
A significant challenge to the broader adoption of veterinary SRS systems is the shortage of trained veterinary oncologists capable of operating the complex equipment and designing effective treatment plans. The precision required for SRS treatment necessitates both technical and clinical expertise, which remains limited in many regions. Additionally, the cost and availability of training programs for veterinary professionals in oncology are insufficient to meet rising demand. These limitations, particularly in rural or underserved areas, hinder the deployment and effective utilization of SRS systems, slowing the market’s overall penetration.Key Market Trends
Increasing Preference for Non-Invasive Treatments
There is a marked shift toward non-invasive treatment methods in veterinary medicine, driven by heightened concern for animal welfare and the desire for improved recovery outcomes. Stereotactic radiosurgery offers an effective, pain-minimizing alternative to traditional surgery, particularly for treating brain and spinal tumors. With faster recovery times, reduced risk of complications, and minimal hospitalization, SRS is becoming increasingly preferred by pet owners and veterinarians alike. As non-invasive methods become more mainstream in both human and animal healthcare, the veterinary field is embracing technologies that enhance treatment precision and pet comfort.Key Market Players
- Avante Health Solutions
- Accuray Inc.
- Elekta AB
- Varian Medical Systems Inc.
- PetCure Oncology
- Xstrahl Inc.
- CVS Group
- Medtronic PLC
- Nanovi AS
- Merck & Co. Inc.
Report Scope:
In this report, the Global Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.Veterinary Stereotactic Radiosurgery System Market, By Product:
- Gamma Knife
- LINAC
- Proton Beam Radiation Therapy (PBRT)/ Flash-RT
- CyberKnife
Veterinary Stereotactic Radiosurgery System Market, By Application:
- Brain Tumours
- Spinal Tumours
- Other Applications
Veterinary Stereotactic Radiosurgery System Market, By End User:
- Veterinary Hospitals
- Veterinary Specialty Clinics
- Research and Academic Institutions
Veterinary Stereotactic Radiosurgery System Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery System Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Veterinary Stereotactic Radiosurgery System Market Outlook
6. North America Veterinary Stereotactic Radiosurgery System Market Outlook
7. Europe Veterinary Stereotactic Radiosurgery System Market Outlook
8. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market Outlook
9. South America Veterinary Stereotactic Radiosurgery System Market Outlook
10. Middle East and Africa Veterinary Stereotactic Radiosurgery System Market Outlook
11. Market Dynamics
12. Market Trends & Developments
13. Porters Five Forces Analysis
14. Competitive Landscape
Companies Mentioned
- Avante Health Solutions
- Accuray Inc.
- Elekta AB
- Varian Medical Systems Inc.
- PetCure Oncology
- Xstrahl Inc.
- CVS Group
- Medtronic PLC
- Nanovi AS
- Merck & Co. Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 182 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 3.46 Billion |
Forecasted Market Value ( USD | $ 6.21 Billion |
Compound Annual Growth Rate | 10.2% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |